Market Cap
₹9,394 Cr.
P/E
0.00
About
Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bangalore, India. The Company has two business verticals, viz., Regulated Markets and Emerging … Read more
Incorporated in 1990, Strides Pharma Science Limited is a global pharmaceutical company headqu… Read more
Low
412
52W Range
High
1032
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
-9.16%
3yr Average
-6.33%
5yr Average
-1.06%
Net Profit Margin
Latest
-5.49%
3yr Average
-4.13%
5yr Average
0.77%
ROCE
Latest
8.2%
3yr Average
5.45%
5yr Average
6.23%
Debt to Equity
Latest
1.25
3yr Average
1.07
5yr Average
1.04
Market Share
50 %
(as of Mar 19)
Acarbose - Market Share
21 %
(as of Mar 19)
Acetazolamide - Market Share
11 %
(as of Mar 19)
Amlodipine - Market Share
18 %
(as of Mar 19)
Benzonatate - Market Share
52 %
(as of Mar 19)
Buspirone - Market Share
36 %
(as of Mar 19)
Calcitriol SGC - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

    Select a Metric
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Pediacare
    Suppliers
    • Laurus Labs Ltd.
    • HLE Glascoat Ltd.
    • IOL Chemicals And Pharmaceuticals Ltd.
    FAQs on Strides Pharma Science Ltd. Business

    Strides Pharma Science Limited is a global pharmaceutical company established in 1990, with headquarters in Bangalore, India. It operates in Regulated Markets and Emerging Markets, with a strong R&D facility and presence in 100 countries.

    Strides Pharma Scien major competitors are Marksans Pharma, Procter&Gamble Healt, FDC, Orchid Pharma, Caplin Point Lab, Jubilant Pharmova, Wockhardt.
    Market Cap of Strides Pharma Scien is ₹9,394 Crs.
    While the median market cap of its peers are ₹9,079 Crs.

    Strides Pharma Scien seems to be less financially stable compared to its peers.
    Altman Z score of Strides Pharma Scien is 2.43 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis